advisorsecurities master

NTHINeOnc Technologies Holdings, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
19338
Ticker
NTHI
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2025-03-26
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
NTHI

Detail

Enriched 2026-08-14 20:47

Market cap
$89,739,822.9
Shares outstanding (class)
25,931,865
Shares outstanding (weighted)
25,936,365
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
5
Location
CALABASAS, CA
Description

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data